期刊文献+

TCM theoretical analysis and modern pharmacological mechanism of Huashi Baidu decoction in treating severe novel coronavirus pneumonia

下载PDF
导出
摘要 The main symptom elements of the severe novel coronavirus pneumonia epidemic virus closed lung syndrome are cold, damp, poisonous, heat, dryness, blood stasis, and deficiency, which mainly involve the lung and spleen, and are closely related to the heart, liver, kidney, and large intestine. Chinese medicine has accumulated rich academic theories and clinical experience in the prevention and treatment of infectious diseases. The treatment of lung syndrome recommends the use of Huashibaidu formula in the treatment of novel coronavirus pneumonia with integrated traditional Chinese and western medicine. The prescription for removing dampness and detoxification is composed of Maxingshigan formula in "Treatise on Febrile Diseases", "Tingli Dazao Xiefei formula" in "An Outline of Jinkui", Xuanbai Chengqi formula in "Diagnosis of Warm Diseases", "Medical Source Moisture" The combination of four prescriptions of Huopu Xialing formula in "On" is made according to the specific requirements. Through the composition of the prescription of Huashibaidu formula and the pharmacological research involving drugs, the mechanism of the novel coronavirus pneumonia severe epidemic closed lung syndrome may be combined with the blocking of cytokine inflammation storm, immune regulation, antispasmodic and asthma, and improvement Related to hemodynamics.
出处 《Journal of Hainan Medical University》 2020年第16期8-11,共4页 海南医学院学报(英文版)
  • 相关文献

参考文献1

二级参考文献10

  • 1Goodman R B, Pugin J, Lee J S, et al. Cytokinemediated inflammation in acute lung injury[ J ]. Cytokine Growth Factor Rev,2003,14 ( 6 ) :523.
  • 2Hailman E, Lichenstein H S, wurfel M M, et al. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14 [J]. J Exp Med, 1994, 179( 1 ) :269.
  • 3Tapping R I, Tobias P S. Celluar binding of soluble CD14 requires lipopolysaccharide (LPS) and LPS- binding protein [ J ]. J Biol Chem, 1997, 272 (37) :23157.
  • 4Le Roy D, Di Padova F, Adachi Y, et al. Critical role of lipopolysaccharide-binding protine and CD14 in immune responses against gram-negative bacteria [ J ]. Immunol, 2001, 167 ( 5 ) : 2759.
  • 5Akashi S, Ogata H, Kirikae F, et al. Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2. [ J]. Biochem Biophys Res Commun, 2000,268( 1 ) : 172.
  • 6Dinarello C A. Interleukin-1 and the pathogenesis of the acute phase response[J]. New Engl J Med, 1984, 311 (22) :1413.
  • 7Heinrich P C, Castell J C, Andus T. Interleukin-6 and the acute phase response [ J]. Biochem J, 1990, 265 (3) :621.
  • 8Beutler B, Cerami A. Cachectin/tumor necrosis factor: an endogenous mediator of shock and inflammation [ J ]. Immunol Res, 1986, 5(4) :281.
  • 9陈奇.中药药理研究方法学[M].北京:人民卫生出版社,1996.33-34.
  • 10李琦,钱桂生,张青,王长征.不同剂量脂多糖对大鼠急性肺损伤效应的观察[J].第三军医大学学报,2004,26(10):871-873. 被引量:52

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部